258 related articles for article (PubMed ID: 33061819)
21. Interphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosis.
North BJ; Verdin E
PLoS One; 2007 Aug; 2(8):e784. PubMed ID: 17726514
[TBL] [Abstract][Full Text] [Related]
22. NQO1 regulates mitotic progression and response to mitotic stress through modulating SIRT2 activity.
Kang HJ; Song HY; Ahmed MA; Guo Y; Zhang M; Chen C; Cristofanilli M; Horiuchi D; Vassilopoulos A
Free Radic Biol Med; 2018 Oct; 126():358-371. PubMed ID: 30114477
[TBL] [Abstract][Full Text] [Related]
23. Modulation Of Microtubule Acetylation By The Interplay Of TPPP/p25, SIRT2 And New Anticancer Agents With Anti-SIRT2 Potency.
Szabó A; Oláh J; Szunyogh S; Lehotzky A; Szénási T; Csaplár M; Schiedel M; Lőw P; Jung M; Ovádi J
Sci Rep; 2017 Dec; 7(1):17070. PubMed ID: 29213065
[TBL] [Abstract][Full Text] [Related]
24. Active nuclear import of the deacetylase Sirtuin-2 is controlled by its C-terminus and importins.
Eldridge MJG; Pereira JM; Impens F; Hamon MA
Sci Rep; 2020 Feb; 10(1):2034. PubMed ID: 32042025
[TBL] [Abstract][Full Text] [Related]
25. SIRT2 and SIRT3 expression correlates with redox imbalance and advanced clinical stage in patients with multiple myeloma.
Allegra A; Innao V; Polito F; Oteri R; Alibrandi A; Allegra AG; Oteri G; Di Giorgio RM; Musolino C; Aguennouz M
Clin Biochem; 2021 Jul; 93():42-49. PubMed ID: 33861984
[TBL] [Abstract][Full Text] [Related]
26. SIRT2 promotes murine melanoma progression through natural killer cell inhibition.
Zhang M; Acklin S; Gillenwater J; Du W; Patra M; Yu H; Xu B; Yu J; Xia F
Sci Rep; 2021 Jun; 11(1):12988. PubMed ID: 34155309
[TBL] [Abstract][Full Text] [Related]
27. SIRT2 regulates NF-κB dependent gene expression through deacetylation of p65 Lys310.
Rothgiesser KM; Erener S; Waibel S; Lüscher B; Hottiger MO
J Cell Sci; 2010 Dec; 123(Pt 24):4251-8. PubMed ID: 21081649
[TBL] [Abstract][Full Text] [Related]
28. SUMOylation is essential for Sirt2 tumor-suppressor function in neuroblastoma.
Lu W; Wang Q; Xu C; Yuan H; Fan Q; Chen B; Cai R; Wu D; Xu M
Neoplasia; 2021 Jan; 23(1):129-139. PubMed ID: 33316537
[TBL] [Abstract][Full Text] [Related]
29. E3 Ubiquitin Ligase HRD1 Promotes Lung Tumorigenesis by Promoting Sirtuin 2 Ubiquitination and Degradation.
Liu L; Yu L; Zeng C; Long H; Duan G; Yin G; Dai X; Lin Z
Mol Cell Biol; 2020 Mar; 40(7):. PubMed ID: 31932479
[TBL] [Abstract][Full Text] [Related]
30. Functional characterization of NAD dependent de-acetylases SIRT1 and SIRT2 in B-Cell Chronic Lymphocytic Leukemia (CLL).
Bhalla S; Gordon LI
Cancer Biol Ther; 2016; 17(3):300-9. PubMed ID: 26794150
[TBL] [Abstract][Full Text] [Related]
31. A novel sirtuin 2 (SIRT2) inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancer.
Hoffmann G; Breitenbücher F; Schuler M; Ehrenhofer-Murray AE
J Biol Chem; 2014 Feb; 289(8):5208-16. PubMed ID: 24379401
[TBL] [Abstract][Full Text] [Related]
32. SIRT2 regulates oxidative stress-induced cell death through deacetylation of c-Jun NH
Sarikhani M; Mishra S; Desingu PA; Kotyada C; Wolfgeher D; Gupta MP; Singh M; Sundaresan NR
Cell Death Differ; 2018 Sep; 25(9):1638-1656. PubMed ID: 29449643
[TBL] [Abstract][Full Text] [Related]
33. Sirt2 is a novel in vivo downstream target of Nkx2.2 and enhances oligodendroglial cell differentiation.
Ji S; Doucette JR; Nazarali AJ
J Mol Cell Biol; 2011 Dec; 3(6):351-9. PubMed ID: 21669943
[TBL] [Abstract][Full Text] [Related]
34. SIRT2 regulates tumour hypoxia response by promoting HIF-1α hydroxylation.
Seo KS; Park JH; Heo JY; Jing K; Han J; Min KN; Kim C; Koh GY; Lim K; Kang GY; Uee Lee J; Yim YH; Shong M; Kwak TH; Kweon GR
Oncogene; 2015 Mar; 34(11):1354-62. PubMed ID: 24681946
[TBL] [Abstract][Full Text] [Related]
35. Deacetylation of the mitotic checkpoint protein BubR1 at lysine 250 by SIRT2 and subsequent effects on BubR1 degradation during the prometaphase/anaphase transition.
Suematsu T; Li Y; Kojima H; Nakajima K; Oshimura M; Inoue T
Biochem Biophys Res Commun; 2014 Oct; 453(3):588-94. PubMed ID: 25285631
[TBL] [Abstract][Full Text] [Related]
36. Quantitative proteomic analysis of the lysine acetylome reveals diverse SIRT2 substrates.
Zhang H; Dammer EB; Duong DM; Danelia D; Seyfried NT; Yu DS
Sci Rep; 2022 Mar; 12(1):3822. PubMed ID: 35264593
[TBL] [Abstract][Full Text] [Related]
37. Molecular cloning, expression and subcellular distribution of an alternative splice variant of the porcine Sirt2 gene.
Liu B; Liu F; Bai L; Li Y; Yang G
Mol Biol Rep; 2010 Mar; 37(3):1671-6. PubMed ID: 19823955
[TBL] [Abstract][Full Text] [Related]
38. SIRT2 Regulates LPS-Induced Renal Tubular CXCL2 and CCL2 Expression.
Jung YJ; Lee AS; Nguyen-Thanh T; Kim D; Kang KP; Lee S; Park SK; Kim W
J Am Soc Nephrol; 2015 Jul; 26(7):1549-60. PubMed ID: 25349202
[TBL] [Abstract][Full Text] [Related]
39. Sirt2 deacetylase is a novel AKT binding partner critical for AKT activation by insulin.
Ramakrishnan G; Davaakhuu G; Kaplun L; Chung WC; Rana A; Atfi A; Miele L; Tzivion G
J Biol Chem; 2014 Feb; 289(9):6054-66. PubMed ID: 24446434
[TBL] [Abstract][Full Text] [Related]
40. ERK1/2 regulates SIRT2 deacetylase activity.
Choi YH; Kim H; Lee SH; Jin YH; Lee KY
Biochem Biophys Res Commun; 2013 Jul; 437(2):245-9. PubMed ID: 23806683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
